Objectives

Objectives of Pharmacological Monitoring

The aims of the pharmacological monitoring project are:

To provide a Europe-wide monitoring service free of charge (sample transportation and plasma-level determination) for a period of 3 years.
To construct a database that will verify the imatinib therapeutic threshold by following patients with trough plasma levels < 1000 ng/mL
To identify and certify laboratories across Europe, and establish imatinib plasma-level determination services within the respective countries, in collaboration with the central facility in Bordeaux, France (laboratory of Prof. Mathieu Molimard, Department of Clinical Pharmacology and Toxicology, Pellegrin Hospital and University Victor Segalen, Bordeaux).

Created by: Hellenbrecht , generated 2007/12/19 , last changed: 2008/01/08

European LeukemiaNet